A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...

Drugmaker Novartis’ Super Bowl ad explained that prostate cancer screening starts with a simple blood test, aiming to dispel fear of an exam for a treatable cancer.

The FDA is expected to decide on treatments for acquired hypothalamic obesity, dry eye disease, primary biliary cholangitis, psoriatic arthritis, and severe leukocyte adhesion deficiency-I.

Super Bowl ad puts male reproduction gland in the spotlight. But is that specific prostate test the best method based on experts' recommendation?

Almost three-fourths of patients with biochemically recurrent prostate cancer remained metastasis free at 5 years following ...

Meta has now rolled out the "Build Your 2026 Algorithm" feature for Instagram Reels to allow users use it to personalize their feeds. Instagram Reels 'Build Your 2026 Algorithm' Now Live After a test ...

CHARLOTTE — PSA Airlines, a subsidiary of American Airlines Group, officially opened its new headquarters in Charlotte, completing its relocation from Dayton, Ohio without any state or local ...

The implementation of a nephroprotective prevention care strategy significantly reduced the risk for acute kidney injury (AKI) following major surgery among high-risk patients, according to a new ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

On Thursday morning, hours before President Donald Trump signed an executive order designed to stop states from regulating artificial intelligence, a trio of child safety advocacy groups began airing ...

For the first time, Instagram will start letting you control the topics its algorithm recommends, much as you now can on TikTok. The new feature is starting with the Reels tab but will eventually come ...